IGF-1 DES PEPTIDE 1MG VIAL

IGF-1 DES (Insulin-like Growth Factor-1 DES 1-3) is a highly potent, truncated variant of the naturally occurring IGF-1 peptide. It is structurally modified by the removal of the first three amino acids at the N-terminus. This crucial alteration prevents the peptide from binding to IGF-binding proteins (IGFBPs) in the bloodstream, effectively rendering it significantly more bioavailable and up to ten times more potent than standard, unmodified IGF-1 at the receptor site. Because it possesses an exceptionally short active half-life (roughly 20 to 30 minutes), its primary mechanism of action relies on rapid, highly localized cellular signaling. In advanced research and extreme physical optimization protocols, IGF-1 DES is heavily utilized for site-specific administration to forcefully induce localized skeletal muscle hyperplasia (the actual creation of entirely new muscle fibers), drive intense nutrient partitioning into the target area, and aggressively accelerate localized tissue repair immediately following severe mechanical stress.